Covered Call Analyzer Aggressive "STOCKS-TO-CONSIDER"     

  for July, 2005                                                                                    Close Window

Company Name

Stock Symbol

Stock Price

# of shares

Total Cost*

 Option Symbol

 Aug Option Price

Income from sale*

Strike Price

Projected return if Called after one month*

Actual 

$ 

return*

Actual 

% 

Return*

Adolor Corp.

(risky)

 ADLR $10.06 900 $9,074 UAHHV $1.00 $877 12.5 33% ($740) -8%
Comments:

Exercised get-out price at $8.55 after buying back calls at 0.26.
Eyetech Pharm. EYET $13.45 700 $9,435 QUJHC $0.75 $505 15 16% +$2,354 +25%
Comments:

Not called. Will now sell Sep15 at 1.15. Called.
Sigmatel Incorporated SGTL $18.40 500 $9,220 UGOHD $0.75 $358 20 12% +$1,395 +15%
Comments:

Not called. Will now sell Sep20 at 0.55. Called.

Stamps.com

 STMP $18.45 500 $9,245 JXQHD $0.65 $308 20 11% ($315) -3%
Comments:

Not called. Will now sell Sep20 at 0.25. Not called. Sold all shares at $16.99 to close out position.
Audible, Inc. ADBL $19.27 500 $9,655 OBQHD $1.40 $683 20 10% ($860) -9%
Comments:

Exercised get-out price at $16.38 after buying back calls at 0.16.

Atherogenics, Inc. 

 AGIX $16.75 500 $8,395 AUBHW $1.10 $533 17.5 10% +$1,045 +12%
Comments:

Not called. Will now sell Sep17.5 at 0.35. Called.
Jupitermedia Corp. JUPM $18.93 500 $9,485 EUUHD $0.90 $433 20 10% ($1,120) -12%
Comments:

Exercised get-out price at $16.09 after buying back calls at 0.23.
Penwest Pharma. PPCO $11.95 800 $9,418 OGQHV $0.55 $418 12.5 9% +$936 +10%
Comments:

Not called. Will now sell Sep12.5 at 0.15. Called.
Telik, Inc. TELK $16.78 500 $8,410 ZULHW $0.80 $383 17.5 9% ($422) -5%
Comments:

Not called. Sold all shares at $15.17 to close out position.
PortalPlayer, Inc. PLAY $24.43 400 $9,792 PQPHE $1.10 $424 25 6% +$976 +10%
Comments:

Not called. Will now sell Sep25 at 0.90. Called.

All positions closed out with value up +$3,250.

*After the effect of all commissions.

The stocks listed above are for illustrative and educational purposes only and should not be construed as an endorsement, recommendation, or solicitation to buy or sell any particular security.

top